Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients

Chinese Journal of Medical Genetics

Volumn 19, Issue 5, 2002, Pages 393-396

  Guan, Lixue ^a   Ji, Xiangwu ^a   Wang, Jingxian ^a   Zhang, Aiyuan ^a   Zhang, Yanzhen ^a   Zhao, Limei ^a  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

Coronary heart disease; Genetic polymorphism; Plasminogen activator inhibitor 1

Indexed keywords

DISEASES; ENZYMES; GENES; PATIENT MONITORING;

POLYMERASE CHAIN REACTION; POLYMORPHISM;

GENETIC ENGINEERING;

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ALLELISM; ARTICLE; CHINESE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC;

EID: 0036800475     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brockman MJ, Schwendemann G, Stief TW. Plasminogen activator inhibitor in acute stroke. Mol Chem Neuropathol, 1991, 14: 143-150.
2. Green F, Humphries S. Genetic determinants of arterial thrombosis. Bailliere's Clin Haematol, 1994, 7: 675-692.
3. Vawson S, Hamsten A, Wiman B, et al. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arteriosclerosis Thromb, 1991, 11: 183-190.
4. Dawson SJ, Wiman B, Hamsten A, et al. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem, 1993, 268: 10739-10745.
5. Gardemann A, Lohre J, Katz N, et al. The 4G/4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost, 1999, 82: 1121-1126.
6. Ridker PM, Hennekens CH, Lindpaintinerk C, et al. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor 1 gene in a large cohort of US men. Circulation, 1997, 95: 59-62.
7. Anderson JL, Muhlestein JB, Habashi J, et al. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J Am Coll Cardiol, 1999, 34: 1778-1783.
8. Guan LX, Zhang AJ, Song BH, et al. The relationship between angiotensinogen gene CD235 Met → Thr substitution polymorphism and brain infarction in Chinese. Chin J Med Genet, 2000, 17: 336-339.
9. Visanji JM, Seargent J, Tahri D. et al. Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor promoter on thrombotic risk in patients with factor V Leiden. Br J Haematol, 2000, 110: 135-138.
10. Li W, Cai ZM, Zhang Q, et al. Association between very low density lipoprotein receptor gene (CGG)n polymorphism and non-insulin-dependent-diabetes in Chinese patients. Chin J Med Genet, 1999, 16: 265-266.
11. Margalion M, Cappucci G, Colaizzo D, et al. The PAI-1 gene locus 4G/5G is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol, 1998, 18: 152-156.
12. Mikkelsson J, Perola M, Wartiovaarau U, et al. Plasminogen activator inhibitor-1 (PAT-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly. Thromb Haemost, 2000, 84: 78-82.
13. Ossei-Gerning N, Mansfield MW, Stickland MH, et al. Plasminogen activator history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol, 1997, 17: 33-37.
14. Wong TY, Poon P, Szeto CC, et al. Association of plasminogen activator inhibitor-1 4G/5G genotype and type 2 diabetic nephnopathy in Chinese patients. Kidney Int, 2000, 57: 632-638.
15. Menges T, Hermans PW, Little SG, et al. Plasminogen-activator-in-hibitor-1 4G/5G promoter polymorphism and prognosis of severely I injured patients. Lancet, 2001, 357: 1096-1097.